CD34 and acute myeloid leukemia: Elevated expression of XLOC_091701 in AML cells was confirmed in a larger, internal validation cohort (KAW cohort: AML, n = 103; NBM CD34+, n = 11; P < 0.05; log2 fold change = 1.96; Supplementary Table 2; Fig. 1A).